Scholars Central

Conference abstractPublished 27 Mar 2023

Genetic diversity and amino acids variations at vaccine target sites in rabies viruses collected from different host species in Makueni and Siaya counties, Kenya

Authors: Evalyne Wambugu, Kimita Gathii, Sarah Kituyi, Michael Washington, Clement Masakhwe, Lucy Mutunga, Gurdeep Jaswant, SM Thumbi, Brian Schaefer, John Waitumbi

University of Embu, Kenya United States Army Medical Research Unit, Kenya Uniformed Services University, USA University of Nairobi, Kenya

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Rabies, a viral disease that causes lethal encephalitis is endemic in Kenya and is transmitted to humans mainly by domestic dogs. Rabies kills an estimated 2000 people annually, despite there being effective vaccines for dogs and humans. This study characterized the genetic diversity of RABV obtained from brains of suspected rabid animals from Makueni county, Eastern region and Siaya county, Western Kenya and determined variances within the antigenic sites of RABV vaccines currently in use in Kenya. Methods: Brain biopsies (165) confirmed positive for rabies with rapid kits were collected between July 2021 and August 2022 from dogs, cats, cows, sheep and goats and re-screened for RABV by qPCR. Whole Genome Sequences (WGS) and individual Nucleoprotein (N) and Glycoprotein (G) genes were used for phylogeny. The amino acid variances in the N and G genes antigenic sites were compared to three RABV vaccine sequences: Pitman-Moore L503 (PM), Challenge Virus Standard (CVS) and the Pasteur Vaccine (PV) strains. Results: Of the 165 brain samples, 156 were positive by qPCR and 141 (74 from Makueni and 67 from Siaya) produced useable sequences. Phylogenetic lineages drawn from WGS or from individual N and G genes showed two geographical distinct lineages: The Eastern Kenya sequences overwhelmingly (n=69) clustered with the Africa 1b lineage, with only 3 in Africa 1a. In contrast, the Western Kenya sequences (n=64) clustered with Africa 1a with only 3 in Africa 1b. The nearest common ancestor of the Africa 1a traced to Sudan, while the Africa 1b traced to Tanzania. The percent amino acid homologies of the N gene to the RABV vaccines were at least 97.6% for PV, 97.8% for CVS and 98.5% for PM. The homology with the G gene was at least 93.0% for PV, 93.3% for CVS and 92.2% for PM. Conclusions: Our data confirm geographical isolation of RABV in Eastern and Western Kenya. The data suggests limited migration, probably through wild carnivore movement or translocation of domestic dogs by humans. The observed amino acid variances RABV vaccines antigenic sites would predict good vaccine efficacy, indicating that the RABV endemicity in Kenya is due limited programmatic vaccine coverage.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Infectious Diseases & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Infectious Diseases & Therapy
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Evalyne Wambugu”
  • BylineArticles whose byline prints “Kimita Gathii”
  • BylineArticles whose byline prints “Sarah Kituyi”
  • BylineArticles whose byline prints “Michael Washington”
  • BylineArticles whose byline prints “Clement Masakhwe”
  • BylineArticles whose byline prints “Lucy Mutunga”
  • BylineArticles whose byline prints “Gurdeep Jaswant”
  • BylineArticles whose byline prints “SM Thumbi”